Drug Search Results
More Filters [+]

Ethionamide

Alternative Names: ethionamide, trecator
Latest Update: 2023-01-19
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Cell Wall Synthesis Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intramuscular,Intravenous,Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Brazil | Chile | China | Colombia | Greece | India | Malaysia | Pakistan | Peru | Philippines | Portugal | Romania | Russia | Saudi Arabia | South Africa | Taiwan | Thailand | Turkey | Ukraine | United Kingdom | United States | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ethionamide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title